135 related articles for article (PubMed ID: 10722238)
1. In vivo assessment of a novel dacron surface with covalently bound recombinant hirudin.
Wyers MC; Phaneuf MD; Rzucidlo EM; Contreras MA; LoGerfo FW; Quist WC
Cardiovasc Pathol; 1999; 8(3):153-9. PubMed ID: 10722238
[TBL] [Abstract][Full Text] [Related]
2. Covalent linkage of recombinant hirudin to poly(ethylene terephthalate) (Dacron): creation of a novel antithrombin surface.
Phaneuf MD; Berceli SA; Bide MJ; Quist WC; LoGerfo FW
Biomaterials; 1997 May; 18(10):755-65. PubMed ID: 9158859
[TBL] [Abstract][Full Text] [Related]
3. Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activity.
Phaneuf MD; Szycher M; Berceli SA; Dempsey DJ; Quist WC; LoGerfo FW
Artif Organs; 1998 Aug; 22(8):657-65. PubMed ID: 9702317
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering of a novel small diameter polyurethane vascular graft with covalently bound recombinant hirudin.
Phaneuf MD; Dempsey DJ; Bide MJ; Szycher M; Quist WC; LoGerfo FW
ASAIO J; 1998; 44(5):M653-8. PubMed ID: 9804516
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake.
Berceli SA; Phaneuf MD; LoGerfo FW
J Vasc Surg; 1998 Jun; 27(6):1117-27. PubMed ID: 9652474
[TBL] [Abstract][Full Text] [Related]
6. Thrombin inhibition by covalently bound hirudin.
Ito RK; Phaneuf MD; LoGerfo FW
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):77-81. PubMed ID: 1773001
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of a recombinant hirudin-albumin complex.
Phaneuf MD; Ito RK; LoGerfo FW
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):641-5. PubMed ID: 7841322
[TBL] [Abstract][Full Text] [Related]
8. Modification of polyethylene terephthalate (Dacron) via denier reduction: effects on material tensile strength, weight, and protein binding capabilities.
Phaneuf MD; Quist WC; Bide MJ; LoGerfo FW
J Appl Biomater; 1995; 6(4):289-99. PubMed ID: 8589514
[TBL] [Abstract][Full Text] [Related]
9. Covalent linkage of streptokinase to recombinant hirudin: a novel thrombolytic agent with antithrombotic properties.
Phaneuf MD; Ozaki CK; Johnstone MT; Loza JP; Quist WC; LoGerfo FW
Thromb Haemost; 1994 Apr; 71(4):481-7. PubMed ID: 8052967
[TBL] [Abstract][Full Text] [Related]
10. Experimental evaluation of bleeding complications, thrombogenicity and neointimal characteristics of prosthetic patch materials used for carotid angioplasty.
Rhee RY; Gloviczki P; Cambria RA; Miller VM
Cardiovasc Surg; 1996 Dec; 4(6):746-52. PubMed ID: 9013003
[TBL] [Abstract][Full Text] [Related]
11. [The effect of preclotting and collagen coating on endothelializing rate and thrombogenesity of Dacron grafts in the canine thoracic aorta].
Niibori K; Ito Y; Uchida N; Akino Y; Tofukuji M; Syouji Y; Yoshida S; Tabayashi K; Mohri H
Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):508-15. PubMed ID: 8035069
[TBL] [Abstract][Full Text] [Related]
12. Effects of albumin coating of knitted Dacron grafts on transinterstitial blood loss and tissue ingrowth and incorporation.
Kang SS; Petsikas D; Murchan P; Cziperle DJ; Ren D; Kim DU; Greisler HP
Cardiovasc Surg; 1997 Apr; 5(2):184-9. PubMed ID: 9212205
[TBL] [Abstract][Full Text] [Related]
13. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
[TBL] [Abstract][Full Text] [Related]
14. The influence of early surface thromboreactivity on long-term arterial graft patency.
Rumisek JD; Wade CE; Kaplan K; Okerberg CV; Corley JH; Barry MJ; Clarke JS
Surgery; 1989 May; 105(5):654-61. PubMed ID: 2523090
[TBL] [Abstract][Full Text] [Related]
15. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
[TBL] [Abstract][Full Text] [Related]
16. Experimental evaluation of a new albumin-impregnated knitted dacron prosthesis.
McGee GS; Shuman TA; Atkinson JB; Weaver FA; Edwards WH
Am Surg; 1987 Dec; 53(12):695-701. PubMed ID: 2962524
[TBL] [Abstract][Full Text] [Related]
17. Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
Mohamed MS; Mukherjee M; Kakkar VV
J R Coll Surg Edinb; 1998 Jun; 43(3):155-7. PubMed ID: 9654873
[TBL] [Abstract][Full Text] [Related]
18. Heat-denatured albumin-coated Dacron vascular grafts: physical characteristics and in vivo performance.
Rumisek JD; Wade CE; Brooks DE; Okerberg CV; Barry MJ; Clarke JS
J Vasc Surg; 1986 Aug; 4(2):136-43. PubMed ID: 2942709
[TBL] [Abstract][Full Text] [Related]
19. A collagen coated vascular prosthesis.
Scott SM; Gaddy LR; Sahmel R; Hoffman H
J Cardiovasc Surg (Torino); 1987; 28(5):498-504. PubMed ID: 2958479
[TBL] [Abstract][Full Text] [Related]
20. The effect of preclotting on surface thrombogenicity and thromboembolic complications of Dacron grafts in the canine thoracic aorta.
Gloviczki P; Hollier LH; Hoffman EA; Plate G; Trastek VF; Kaye MP
J Thorac Cardiovasc Surg; 1984 Aug; 88(2):253-8. PubMed ID: 6235404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
